CV Risk Reduced with Roux-en-Y Gastric Bypass


eMediNexus    21 January 2018

In addition to both intensive lifestyle modification and medical management, Roux-en-Y gastric bypass surgery showed a long-term improvement in glycemic control, blood pressure, and lipids, suggested a new randomized trial published online in the Journal of the American Medical Association. In the 5-year follow-up, adding gastric bypass to intensive lifestyle and medical management continued to show improved attainment of the triple diabetes endpoint goal.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.